Laboratory evaluation reveals new sesquiterpenes inhibit Chlamydia abortus in cell cultures, indicating potential for therapeutic use.
Three new eremophilane-type sesquiterpenoids (1-3), along with two known eremophilenolides (4-5), were obtained from the whole of Ligularia macrophylla. The structures were determined by spectroscopic analysis and comparison with reported data. Compounds 1-5 were evaluated for their antichlamydial activities by an experimental model employing L929 cells infected with Chlamydia abortus. Compound 3, at a concentration of 100 µM, exhibited activity comparable to that of the positive control tetracycline at a concentration of 20 µg/mL, while showing no cytotoxicity. Preliminary structure-activity relationships for these eremophilenolides are reported.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: